Fungal infection is a rare but devastating complication of total joint arthroplasty. Many patients require removal of the components and resection arthroplasty for cure; however, revision arthroplasty with medicated polymethylmethacrylate bone cement may be used to salvage the joint. Some studies have documented the efficacy of mixing antibiotics with polymethylmethacrylate, but the efficacy of antifungal drugs when mixed with polymethylmethacrylate is unknown. An in vitro agar diffusion method was used in the current study to investigate this potential, and several clinically important conclusions resulted: (1) after incorporation into bone cement, fluconazole and amphotericin B remained active whereas 5-flucytosine did not, (2) inhibitory activity improved with greater drug concentra-tions, and (3) more drug eluted from Palacos® R than Simplex® P cement.
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The outcomes of fungal infections complicating total joint arthroplasty are poorer than their bacterial counterparts. Treatment often consists of resection arthroplasty without reimplantation of the prosthetic components, 1, 6, 7, [9] [10] [11] [12] [13] [14] [15] [16] and only four articles report attempts at reimplantation. 1, 9, 19, 22 One study used antifungal impregnated polymethylmethacrylate bone cement, 19 but the efficacy of this mixture has not been proven. The introduction of antibiotic impregnated bone cement improved the results of revision arthroplasty for bacterial sepsis, 5 and a similar role for antifungal impregnated cement for fungal infections is anticipated. This potential was evaluated for three antifungals and two bone cements using an agar diffusion assay.
METHOD AND MATERIALS
The diffusion of three antifungal drugs, amphotericin B (Gensia Sicor, Irvine, CA), fluconazole (Pfizer, New York, NY), and 5-flucytosine (ICN Laboratories, Costa Mesa, CA), when impregnated in polymethylmethacrylate bone cement, was studied using an agar diffusion assay (Fig 1) . Each drug was mixed thoroughly with polymethylmethacrylate bone cement under sterile conditions. The mix-ture was placed in polytetrafluoroethylene molds to make disc specimens of a designated size. The molds were sandwiched between two solid polytetrafluoroethylene slabs to pressurize the cement. After curing, the discs were tamped free and immediately used for assay.
A 24-to 48-hour agar culture of Candida parapsilosis (American Type Culture Collection Number 22019) was used for all the agar diffusion tests. This isolate is susceptible to all three antifungals tested with minimum inhibitory concentrations to amphotericin B, fluconazole, and 5-flucytosine of 0.5, 4.0, and 0.25 g/mL, respectively.
Organisms were suspended in T-soy broth to a 0.5 MacFarland turbidity standard. A Mueller-Hinton agar plate (BD Microbiology Systems, Sparks, MD) was streaked for confluent growth followed by application of an antifungal impregnated polymethylmethacrylate disc to the center of each agar plate. The plates were incubated at 30ЊC and examined at 24, 48, and 72 hours. Zones of growth inhibition around each disc were measured, photographed digitally, and analyzed using custom digital image processing software (Walter A. Hoyt Jr. Musculoskeletal Research Laboratory, Akron, OH). Control plates with polymethylmethycrylate discs containing no drug also were prepared and analyzed.
Five series of experiments were conducted. In the first, 1 ⁄ 2 an average daily dose for each drug (36 mg amphotericin, 1 ϫ 10 4 mg 5-flucytosine, and 400 mg fluconazole) was mixed with 20 g of the powder component of Simplex® P bone cement (Howmedica Inc, Rutherford, NJ) to produce discs measuring 0.5 inches in diameter by 3 ⁄ 16 inches in height. In the second, one and two times the average daily doses of amphotericin and fluconazole were added to 40 g of the powder component of Sim-plex® P to again make discs measuring 0.5 inches in diameter by 3 ⁄ 16 inches in height. In the third, one and two times the average daily doses of fluconazole were mixed with 40 g of the powder component of Simplex® P to make discs measuring 0.5 inches in diameter and either 1 ⁄ 4 inch or 1 ⁄ 8 inch in height. In the fourth series, one average daily dose of fluconazole was added to 40 g of the powder components of Simplex® P and Palacos® R (Biomet Inc, Warsaw, IN) bone cements to make discs measuring 0.5 inches diameter by 3 ⁄ 16 inch in height. In the fifth series, zones of inhibition from 0.5 inch ϫ 3 ⁄ 16 inch discs of Palacos R impregnated with one average daily dose of fluconazole were measured at 24 hours. This disc was switched to a freshly streaked dish and the zone of inhibition measured 24 hours later. The same disc was switched again and measured after 24 hours (72 hours total).
Two-way analysis of variance was used to analyze the data from each experiment. Significance was accepted for probability less than 0.05 in each case.
RESULTS

First Experiment
Amphotericin B and fluconazole produced measurable zones of growth inhibition; however 5-flucytosine and the control did not. The lack of inhibition by 5-flucytosine seen in these tests was used as the rationale for elimination of 5-flucytosine from additional testing.
Second Experiment
The zones of growth inhibition increased with doubling of the drug dosage. The areas of the zones for amphotericin B increased an average of 81.88 mm 2 (p Ͻ 0.001) and those for fluconazole increased an average of 818.82 mm 2 (p ϭ 0.0001), at 24 hours.
Third Experiment
The discs 1 ⁄ 4 inch in height cleared significantly larger zones (p Ͻ 0.001) than the shorter discs ( Fig 2) ; however, the concentration of drug contributed more to zone size than the height of the disc (F values, height ϭ 108.97 and concentration ϭ 360.76).
Fourth Experiment
The zones of growth inhibition produced by discs made of Palacos R were significantly larger than those produced by discs of Simplex P at 24, 48, and 72 hours (p ϭ 0.0001).
Fifth Experiment
The zones of growth inhibition at 24 hours were significantly greater (p ϭ 0.001) than those seen at 48 and 72 hours after switching the discs to freshly streaked dishes (Fig 3) .
The medicated disc had the greatest effect in the first 24 hours of the 72 hour test.
DISCUSSION
The agar diffusion assay test in this investigation does not allow direct comparison between antifungals. Amphotericin B produced smaller zones than fluconazole, but this does not imply less inhibitory action. Inhibitory zone size is a function of the diffusion rate of the drug through the agar in addition to the drug's potency. Additional factors influencing zone size include the drug's molecular weight and charge. Amphotericin B and fluconazole had inhibitory activity after mixing in polymethylmethacrylate, but quantification of that activity was not possible. 5-flucytosine did not inhibit the organism suggesting that it was inactivated during curing of the polymethylmethacrylate or failed to diffuse through the agar. Inhibitory zones increased with increasing drug concentration in the polymethylmethacrylate. The limit of drug concentration attributable to toxicity is unknown, although a preliminary quantitative study from this institution indicated that only a fraction of incorporated antifungal drug eluted from the cement. (Silverberg DS, Kodali P, Dipersio J: Unpublished data. Akron, OH, Walter Hoyt Jr. Musculoskeletal Research Laboratory.) High pressure liquid chromotomagraphy measured the elution of fluconazole from one disc during 24 hours and showed only 2.055ϫ10 Ϫ5 g (0.19%) elution from a disc containing 1/100 g of the drug. The small percentage of drug eluted suggests that dosing at levels greater than those applicable to systemic therapy is safe. The study showed that the greatest effect of an antifungal disc occurs in the initial 24 hours (Fig  3) , therefore concern over toxicity from drug elution beyond the measured periods is unwarranted. Studies measuring elution of antibiotics from bone cement have shown similar low levels. 3, 17 The mechanism of elution is controversial. Early studies suggested a slow diffusion of drug through the cement. 3, 8, 18, 20, 21 Zones of inhibition were measured for fluconazole discs of two different concentrations and heights. Taller discs produced larger zones of inhibition (p Ͻ 0.001); however, the concentration of the discs contributed more to zone size than the height of the discs (1 ADD ϭ average daily dose, 2 ADD ϭ double average daily dose). thors reported that the available drug rests in pores near the surface and dissolves by direct contact with the surrounding medium. 2, 17 Several conclusions from the current study lend support for the latter mechanism. Palacos R bone cement is more porous than Simplex P, therefore Palacos R exposes more drug to the surrounding medium and would be expected to clear larger zones of inhibition. Also, the larger zones created by the taller discs more likely represent the effect of heavier (taller) discs that sink into the soft agar and expose more drug to the medium rather than diffusion of drug from the extra cement matrix. Shorter discs with higher drug concentrations at the disc surface tend to create larger zones than taller discs with lower concentrations (Fig 2) . The prime determinant of elution is the surface area in contact with the surrounding medium, thus a batch of cement molded into a block spacer for revision surgery is likely to be less effective in terms of its inhibitory effect than a batch divided into smaller portions. A recent report documented two cases of fungal infected prosthetic joints successfully treated by fluconazole polymethylmethacrylate beads inserted at the time of debridement. 4 Polymethylmethacrylate bone cement loaded with antifungal drug inhibits fungal growth in an agar diffusion assay. Two of the three antifungals tested, amphotericin B and fluconazole, created zones of inhibition whereas 5flucytosine did not. The zone size increased with greater drug concentration, and the zones created around Palacos R specimens were larger than those created around Simplex P. These conclusions support mixing amphotericin B and fluconazole in bone cement in the treatment of fungal infected prosthesis.
